Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Prostate Cancer and Prostatic Diseases|May 7, 2014
Characterization of prostate neuroendocrine cancers and therapeutic management: a literature reviewP Sargos, L Ferretti, M Gross-Goupil, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 11, 2024
Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approachesC Llacer-Moscardo, L Moureau-Zabotto, L Ollivier, et al.
Annals of the Rheumatic Diseases|December 1, 1986
Behçet's disease in Iraqi patientsZ S Al-Rawi, K E Sharquie, S J Khalifa, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendationsJ Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.
Open Access Macedonian Journal of Medical Sciences|March 14, 2020
Quality of Life among Surgical Residents at King Abdulaziz Medical City in Jeddah, Saudi ArabiaMalik M Almailabi, Rakan S Alajmi, Atheel L Balkhy, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 7, 2022
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]G Ploussard, J-B Beauval, R Mathieu, et al.
Actas Urologicas Espanolas|April 4, 2024
Is trimodal therapy the current standard for muscle-invasive bladder cancer?M López Valcárcel, M Barrado Los Arcos, M Ferri Molina, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 22, 2021
Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa)G Peyraga, T Lizee, J Khalifa, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 2022
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]M Baboudjian, J-B Beauval, E Barret, et al.
Pageof 9